1. Home
  2. EVO vs NABL Comparison

EVO vs NABL Comparison

Compare EVO & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.76

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$3.56

Market Cap

945.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
NABL
Founded
1993
2000
Country
Germany
United States
Employees
4553
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
934.1M
945.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EVO
NABL
Price
$2.76
$3.56
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$7.00
$8.31
AVG Volume (30 Days)
95.9K
1.1M
Earning Date
04-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$511,430,000.00
Revenue This Year
$1.37
$11.04
Revenue Next Year
$10.05
$8.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.71
52 Week Low
$2.31
$3.24
52 Week High
$4.80
$9.04

Technical Indicators

Market Signals
Indicator
EVO
NABL
Relative Strength Index (RSI) 41.07 29.45
Support Level $2.32 N/A
Resistance Level $3.78 $5.22
Average True Range (ATR) 0.09 0.34
MACD -0.06 -0.21
Stochastic Oscillator 19.16 13.21

Price Performance

Historical Comparison
EVO
NABL

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

Share on Social Networks: